Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Hong Kong
19129515.3
Filed on 2019-09-11
19129515.3
Filed on 2019-09-11
Viral Methods Of T Cell Therapy
US Application 16/389,586
Filed on 2019-04-19
Filed on 2019-04-19
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
Italy
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
Ireland
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
United Kingdom
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
France
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
Spain
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
Germany
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Methods for Subtyping Lymphoma Types by Means of Expression Profiling
Switzerland
14803288.1
Filed on 2014-11-05
14803288.1
Filed on 2014-11-05
Affinity Matured M971 For CD22 Positive Cancer Therapeutics Development
Patent Cooperation Treaty
PCT/US2019/041401
Filed on 2019-07-11
PCT/US2019/041401
Filed on 2019-07-11